Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ, UK
Aromasin 25 mg coated tablets.
Pharmaceutical Form |
---|
Coated tablet. Round, biconvex, off-white coated tablet marked 7663 on one side. |
Active substance: exemestane.
Each coated tablet contains 25 mg exemestane.
Excipients with known effect: Each tablet contains 30.2 mg of sucrose and 0.003 mg of methyl parahydroxybenzoate (E218).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Exemestane |
Exemestane is an irreversible, steroidal aromatase inhibitor, structurally related to the natural substrate androstenedione. |
List of Excipients |
---|
Tablet core: Silica colloidal hydrated Sugar-coating: Hypromellose Printing ink: Ethyl alcohol |
15, 20, 30, 90, 100 and 120 tablets in blister packs (Aluminium-PVDC/PVC-PVDC)
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ, UK
PL 00057/0930
16th December 1998 / 8th August 2008
Drug | Countries | |
---|---|---|
AROMASIN | Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.